Vycor Medical, Inc.
VYCO
$0.0679
-$0.0001-0.15%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 16.45% | -3.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.45% | -3.79% | |||
| Cost of Revenue | 57.07% | 4.55% | |||
| Gross Profit | 12.23% | -4.58% | |||
| SG&A Expenses | -3.10% | 8.91% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.32% | 9.20% | |||
| Operating Income | 154.99% | -316.67% | |||
| Income Before Tax | 88.80% | -498.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 88.80% | -498.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 88.80% | -498.00% | |||
| EBIT | 154.99% | -316.67% | |||
| EBITDA | 286.60% | -160.82% | |||
| EPS Basic | 97.01% | -2,133.33% | |||
| Normalized Basic EPS | 90.91% | -450.00% | |||
| EPS Diluted | 97.01% | -2,133.33% | |||
| Normalized Diluted EPS | 90.91% | -450.00% | |||
| Average Basic Shares Outstanding | 1.44% | 0.84% | |||
| Average Diluted Shares Outstanding | 1.44% | 0.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||